StocksMedium•26 October 2026•
1 min read
Medifast Beats Q3 Earnings and Revenue Estimates Despite Loss
Key Facts
1Medifast reported a Non-GAAP EPS of -$0.19, beating analyst estimates by $0.16.
2The company's revenue reached $72.05M, surpassing estimates by $0.75M.
Medifast reported a Non-GAAP loss per share of $0.19 for the third quarter, beating analyst estimates by $0.16. Seeking Alpha reported that the company's revenue reached $72.05 million, surpassing market expectations by $0.75 million.
MED closed at $11.87 on October 23, 2026, with the stock trading between a low of $11.67 and a high of $12.10 during that session. These financial results come as revenue decreased 19.4% year-over-year, though the figures remained above the consensus despite the company remaining loss-making.